|
Delayed
Toronto S.E.
09:37:28 2026-11-04 EST
|
5-day change | 1st Jan Change | ||
| 0.0200 CAD | 0.00% |
|
0.00% | -33.33% |
| 09-30 | Earnings Flash (VPI.V) Vitality Products Inc. Reports Q2 Revenue CA$305K | MT |
| 09-29 | Vitality Products Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2026 | CI |
| Market Cap | 828K 593K 529K 485K 441K 56.06M 847K 5.79M 2.32M 29.67M 2.23M 2.18M 94M | P/E 2025 |
-4.25x | P/E 2026 | -34.2x |
|---|---|---|---|---|---|
| Enterprise Value | 707K 506K 451K 414K 376K 47.86M 723K 4.95M 1.98M 25.33M 1.9M 1.86M 80.25M | EV / Sales 2025 |
0.58x | EV / Sales 2026 | 1.78x |
| Free-Float |
51.21% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 month | -33.33% | ||
| 3 months | -20.00% | ||
| Current year | -33.33% |
| 1 month | 0.02 |  | 0.03 |
| Current year | 0.02 | | 0.04 |
| 1 year | 0.02 | | 0.04 |
| 3 years | 0.01 | | 0.06 |
| 5 years | 0.01 | | 0.12 |
| 10 years | 0.01 | | 0.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheryl Grant
CEO | Chief Executive Officer | - | 2018-07-16 |
W. Grant
CEO | Chief Executive Officer | - | 2012-07-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2009-07-20 | |
W. Grant
BRD | Director/Board Member | - | 2011-11-27 |
Cheryl Grant
BRD | Director/Board Member | - | 2015-07-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/6/26 | Buy | Director | 44,000 | 0.1063% | ||
| 7/22/26 | Buy | Chief Executive Officer | 150,000 | 0.3622% | ||
| 7/20/26 | Option | Chief Executive Officer | -100,000 | 0.2415% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -50.00% | -50.00% | 592K | |
| +0.85% | +10.55% | +57.04% | +139.28% | 1,255B | |
| +2.91% | +1.13% | +46.68% | +80.68% | 641B | |
| +1.59% | +1.89% | +34.98% | +106.37% | 505B | |
| +1.25% | -0.73% | +49.96% | +66.94% | 381B | |
| +2.92% | +5.53% | +77.36% | +42.54% | 357B | |
| +2.10% | +3.90% | +32.30% | +59.38% | 303B | |
| +1.92% | +9.87% | +11.94% | +36.47% | 286B | |
| +3.72% | +6.10% | +61.57% | +75.70% | 249B | |
| +4.03% | +9.74% | +42.03% | +115.31% | 208B | |
| Average | +1.96% | +2.65% | +36.39% | +67.27% | 418.52B | |
| Weighted average by Cap. | +1.83% | +3.90% | +48.53% | +93.72% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 793K 568K 506K 464K 422K 53.66M 811K 5.55M 2.22M 28.4M 2.13M 2.09M 89.98M | 863K 618K 551K 505K 459K 58.42M 883K 6.04M 2.42M 30.92M 2.32M 2.27M 97.95M |
| Net income | -146K -105K -93.23K -85.5K -77.7K -9.89M -149K -1.02M -410K -5.23M -393K -384K -16.58M | -48.46K -34.71K -30.93K -28.36K -25.78K -3.28M -49.56K -339K -136K -1.74M -130K -127K -5.5M |
| Net Debt | -163K -116K -104K -95.13K -86.45K -11M -166K -1.14M -456K -5.82M -437K -428K -18.45M | -121K -86.79K -77.34K -70.92K -64.45K -8.2M -124K -848K -340K -4.34M -326K -319K -13.75M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- VPI Stock
Select your edition
All financial news and data tailored to specific country editions
